AAAAAA
Results:
1-7
|
Results: 7
Authors:
GJERTSEN MK
GAUDERNACK G
Citation: Mk. Gjertsen et G. Gaudernack, MUTATED RAS PEPTIDES AS VACCINES IN IMMUNOTHERAPY OF CANCER, Vox sanguinis, 74, 1998, pp. 489-495
Authors:
SAETERDAL I
STRATEN PH
MYKLEBUST JH
KIRKIN AF
GJERTSEN MK
GAUDERNACK G
Citation: I. Saeterdal et al., GENERATION AND CHARACTERIZATION OF GP100 PEPTIDE-SPECIFIC NK-T CELL CLONES, International journal of cancer, 75(5), 1998, pp. 794-803
Authors:
GAUDERNACK G
GJERTSEN MK
Citation: G. Gaudernack et Mk. Gjertsen, MUTANT RAS PEPTIDE VACCINES, European journal of cancer, 33, 1997, pp. 1304-1304
Authors:
GJERTSEN MK
BJORHEIM J
SAETERDAL I
MYKLEBUST J
GAUDERNACK G
Citation: Mk. Gjertsen et al., CYTOTOXIC CD4(-LYMPHOCYTES, GENERATED BY MUTANT P21-RAS (12VAL) PEPTIDE VACCINATION OF A PATIENT, RECOGNIZE 12VAL-DEPENDENT NESTED EPITOPESPRESENT WITHIN THE VACCINE PEPTIDE AND KILL AUTOLOGOUS TUMOR-CELLS CARRYING THIS MUTATION() AND CD8(+) T), International journal of cancer, 72(5), 1997, pp. 784-790
Authors:
GJERTSEN MK
BAKKA A
BREIVIK J
SAETERDAL I
GEDDEDAHL T
STOKKE KT
SOLHEIM BG
EGGE TS
SOREIDE O
THORSBY E
GAUDERNACK G
Citation: Mk. Gjertsen et al., EX-VIVO RAS PEPTIDE VACCINATION IN PATIENTS WITH ADVANCED PANCREATIC-CANCER - RESULTS OF A PHASE I II STUDY/, International journal of cancer, 65(4), 1996, pp. 450-453
Authors:
GJERTSEN MK
SAETERDAL I
THORSBY E
GAUDERNACK G
Citation: Mk. Gjertsen et al., CHARACTERIZATION OF IMMUNE-RESPONSES IN PANCREATIC-CARCINOMA PATIENTSAFTER MUTANT P21 RAS PEPTIDE VACCINATION, British Journal of Cancer, 74(11), 1996, pp. 1828-1833
Authors:
GJERTSEN MK
BAKKA A
BREIVIK J
SAETERDAL I
SOLHEIM BG
SOREIDE O
THORSBY E
GAUDERNACK G
Citation: Mk. Gjertsen et al., VACCINATION WITH MUTANT RAS PEPTIDES AND INDUCTION OF T-CELL RESPONSIVENESS IN PANCREATIC-CARCINOMA PATIENTS CARRYING THE CORRESPONDING RASMUTATION, Lancet, 346(8987), 1995, pp. 1399-1400
Risultati:
1-7
|